VIDEO: Harvoni shows safety, efficacy in adolescents for hepatitis COctober 11, 2016Adolescent MedicineGastroenterologyHepatologyInfectious Diseases
Ombitasvir, paritaprevir, ritonavir, and dasabuvir in CKD patients with HCVOctober 6, 2016GastroenterologyHepatologyInfectious Diseases
Vitamin D deficiency linked to hepatitis B infectionOctober 5, 2016GastroenterologyHepatologyInfectious Diseases
Fulminant HBV reactivation associated with HCV treatmentOctober 4, 2016GastroenterologyInfectious Diseases
Autoimmune-mediated gut dysmotility puts patients at risk for bacterial overgrowthOctober 4, 2016GastroenterologyRheumatology
Nonalcoholic fatty liver disease estimated to cost $103 billion annuallyOctober 4, 2016GastroenterologyHepatologyObesity
Direct-acting antivirals: One of several keys to HCV eradication by 2030October 3, 2016GastroenterologyHepatologyInfectious Diseases
Investigational HCV drug combo yields high SVR12 rates in compensated cirrhosisOctober 1, 2016GastroenterologyHepatology
Analysis yields ‘strong evidence’ for benefit of physical activity in NAFLDOctober 1, 2016EndocrinologyGastroenterologyHepatology
Biologics did not up risk of serious infections in IBDOctober 1, 2016GastroenterologyInfectious Diseases
Targeted HCV patients improve on sofosbuvir/daclatasvir combinationSeptember 29, 2016GastroenterologyHepatologyInfectious Diseases
Nearly half of patients readmitted after liver transplantSeptember 27, 2016HepatologyGastroenterology
